Andrew H. S. Lee

发表

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast

I. Ellis, C. Elston, J. Robertson, 2006, Journal of Clinical Pathology.

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

Ian O Ellis, I. Ellis, A. Green, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

Ian O Ellis, I. Ellis, A. Green, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic markers in triple‐negative breast cancer

Ian O Ellis, I. Ellis, A. Green, 2007, Cancer.

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

Douglas Macmillan, Ian O Ellis, I. Ellis, 2006, European journal of cancer.

Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression?: A Morphological and Molecular Analysis

I. Ellis, S. Humphreys, S. Lakhani, 2005, The American journal of surgical pathology.

An approach to the diagnosis of spindle cell lesions of the breast

I. Ellis, E. Rakha, M. Aleskandarany, 2016, Histopathology.

Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management

I. Ellis, P. Tan, S. Fox, 2016, Histopathology.

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

Ian O Ellis, I. Ellis, S. Pinder, 2005, Modern Pathology.

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

I. Ellis, S. Pinder, Andrew H. S. Lee, 2003, Human pathology.

Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours.

I. Ellis, P. Tan, E. Rakha, 2013, Breast.

Needle core biopsy of the breast

I. Ellis, S. Pinder, C. Elston, 2000 .

Updated UK Recommendations for HER2 assessment in breast cancer

John M S Bartlett, Andrew Hanby, Elena Provenzano, 2014, Journal of Clinical Pathology.

Further evidence that E‐cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study

I. Ellis, A. Green, E. Rakha, 2013, Histopathology.

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

I. Ellis, R. Blamey, A. Green, 2008, European journal of cancer.

Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.

Ian O Ellis, I. Ellis, R. Blamey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

Ian O Ellis, I. Ellis, E. Paish, 2008, Breast Cancer Research.

Angiogenesis and inflammation in ductal carcinoma in situ of the breast

L. Happerfield, L. Bobrow, R. Millis, 1997, The Journal of pathology.

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast

I. Ellis, J. Reis-Filho, M. Lacroix-Triki, 2010, Modern Pathology.

Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast

I. Ellis, E. Rakha, Andrew H. S. Lee, 2010, Modern Pathology.

Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology

D. Treanor, P. Tan, Jeremy S. Thomas, 2018, Journal of Clinical Pathology.

Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family

I. Ellis, J. Reis-Filho, D. Powe, 2008, The American journal of surgical pathology.

Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme

I. Ellis, S. Pinder, E. Rakha, 2017, Histopathology.

High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma

I. Ellis, J. Reis-Filho, D. Powe, 2007, The American journal of surgical pathology.

Encapsulated Papillary Carcinoma of the Breast: An Invasive Tumor With Excellent Prognosis

F. Climent, I. Ellis, E. Rakha, 2011, The American journal of surgical pathology.

Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification

I. Ellis, Z. Hodi, Andrew H. S. Lee, 2011, Journal of Clinical Pathology.

Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses.

Andrew H. S. Lee, Andrew H S Lee, 2005, Breast.

Immunoprofile of metaplastic carcinomas of the breast

I. Ellis, E. Rakha, Z. Hodi, 2017, Histopathology.

Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis

R. Poulsom, L. Bobrow, Andrew H. S. Lee, 1998, The Journal of pathology.

Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?

I. Ellis, E. Rakha, E. Paish, 2013, Modern Pathology.

The prognostic significance of lymphovascular invasion in invasive breast carcinoma

I. Ellis, P. Pharoah, E. Rakha, 2012, Cancer.

Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast

I. Ellis, A. Green, E. Rakha, 2011, Journal of Clinical Pathology.

An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer

I. Ellis, A. Green, D. Powe, 2011, Breast Cancer Research and Treatment.

Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation

I. Ellis, A. Green, D. Powe, 2010, Histopathology.

Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast

S. Pinder, C. Elston, R. Macmillan, 2010, Histopathology.

The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology

I. Ellis, R. Blamey, E. Rakha, 2009, Breast Cancer Research and Treatment.

The Nottingham Prognostic Index for Invasive Carcinoma of the Breast

I. Ellis, Andrew H. S. Lee, 2008, Pathology & Oncology Research.

Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast

I. Ellis, A. Green, E. Rakha, 2008, Breast Cancer Research and Treatment.

Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.

Andrew J Evans, A. Evans, J. Chakrabarti, 2007, AJR. American journal of roentgenology.

Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma

I. Ellis, S. Pinder, C. Elston, 2003, The American journal of surgical pathology.

The histological diagnosis of metastases to the breast from extramammary malignancies

Andrew H. S. Lee, 2006, Journal of Clinical Pathology.

Tubular carcinoma of the breast: further evidence to support its excellent prognosis.

I. Ellis, R. Blamey, E. Rakha, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast

I. Ellis, Z. Hodi, Andrew H. S. Lee, 2012, Histopathology.

CD8+ T lymphocytes infiltrating breast cancer

I. Ellis, A. Green, Andrew H. S. Lee, 2012, Oncoimmunology.

Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening

I. Ellis, E. Rakha, J. Jenkins, 2011, International journal of cancer.

Fibroepithelial tumours of the breast—a review

P. Tan, Andrew H. S. Lee, M. Lerwill, 2021, Virchows Archiv.

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

Kylie L. Gorringe, I. Ellis, A. Green, 2019, British Journal of Cancer.

The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice

I. Ellis, E. Rakha, Andrew H. S. Lee, 2014, Histopathology.

Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?

I. Ellis, E. Rakha, T. D’alfonso, 2016, Histopathology.

National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancer.

I. Ellis, E. Rakha, T. D’alfonso, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recommendations for HER 2 assessment in breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2015 .

Use of immunohistochemistry in the diagnosis of problematic breast lesions

Andrew H. S. Lee, A. Lee, 2013, Journal of Clinical Pathology.

Low-estrogen receptor-positive breast cancer: the impact of tissue sampling, choice of antibody, and molecular subtyping.

I. Ellis, J. Reis-Filho, E. Rakha, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2022, Histopathology.

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

I. Ellis, E. Provenzano, S. Pinder, 2021, British Journal of Cancer.

Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study

F. Beca, E. Rakha, S. Elsheikh, 2019, Journal of Clinical Pathology.

Angiosarcoma arising in the capsule of a mammary silicone implant

H. Burrell, Andrew H. S. Lee, T. Mcculloch, 2022, Diagnostic cytopathology.

Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses.

I. Ellis, E. Rakha, A. Evans, 2010, European journal of cancer.

Outcome of pure mucocele‐like lesions diagnosed on breast core biopsy

I. Ellis, E. Rakha, J. James, 2013, Histopathology.

Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breast

I. Ellis, E. Rakha, Z. Hodi, 2020, Histopathology.

Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?

I. Ellis, E. Rakha, A. Jager, 2011, The Journal of pathology.

The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology

B. Ljung, P. Michelow, T. Sauer, 2019, Acta Cytologica.

The effect of delay in fixation on HER2 expression in invasive carcinoma of the breast assessed with immunohistochemistry and in situ hybridisation

I. Ellis, Z. Hodi, Andrew H. S. Lee, 2014, Journal of Clinical Pathology.

Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis).

I. Ellis, E. Rakha, A. Evans, 2009, European journal of cancer.

Audit of performance of needle core biopsy diagnoses of screen detected breast lesions.

I. Ellis, E. Rakha, A. Evans, 2008, European journal of cancer.

Histological grade of invasive carcinoma of the breast assessed on needle core biopsy – modifications to mitotic count assessment to improve agreement with surgical specimens

I. Ellis, E. Rakha, Z. Hodi, 2011, Histopathology.

Breast Neoplasms with Dermal Analogue Differentiation (Mammary Cylindroma): Report of 3 Cases and a Proposal for a New Terminology

I. Ellis, E. Rakha, A. Shaaban, 2015, Pathobiology.

Comparison of the PharmDx Immunohistochemical System With Standard Methods for Assessing Estrogen and Progesterone Receptors in Invasive Carcinoma of the Breast

I. Ellis, A. Green, E. Paish, 2012, Applied immunohistochemistry & molecular morphology : AIMM.

Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies

I. Ellis, E. Rakha, Z. Hodi, 2020, Histopathology.

Pleomorphic adenoma‐like tumour of the breast

I. Ellis, E. Rakha, M. Aleskandarany, 2016, Histopathology.

UK recommendations for HER2 assessment in breast cancer: an update

I. Ellis, P. Tan, E. Provenzano, 2022, Journal of Clinical Pathology.

Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy – Results from a multicentric UK based study

F. Beca, E. Rakha, S. Elsheikh, 2019 .

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2021, Modern Pathology.

Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia

I. Ellis, E. Rakha, Z. Hodi, 2011, Histopathology.

Accuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast

T. Stephenson, S. Pinder, C. Quinn, 2016, Journal of Clinical Pathology.

Re‐audit of revised method for assessing the mitotic component of histological grade in needle core biopsies of invasive carcinoma of the breast

I. Ellis, E. Rakha, Z. Hodi, 2012, Histopathology.

O-91 Prognostic estimation: re-analysis of data from cases diagnosed in 1990–99 by Cox proportional hazards method

G. Ball, I. Ellis, A. Green, 2007 .

Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy

J. James, Andrew H. S. Lee, E. Giannotti, 2021, European Radiology.

Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer

G. Ball, I. Ellis, S. Pinder, 2014, Clinical Cancer Research.

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

I. Ellis, A. Green, E. Rakha, 2019, British Journal of Cancer.

Malignant phyllodes tumour of the breast mimicking endometriosis

P. Tan, B. Teh, C. Ng, 2021, Virchows Archiv.

Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.

I. Ellis, E. Rakha, J. James, 2023, Histopathology.

The significance of lobular neoplasia on needle core biopsy of the breast

I. Ellis, C. Elston, A. Evans, 2008, Virchows Archiv.

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland –on behalf of the UK national coordinating committee for breast pathology

E. Provenzano, S. Pinder, E. Rakha, 2023, Breast.

Preoperative assessment of prognostic factors in breast cancer

I. Ellis, S. Pinder, C. Elston, 2001, Journal of clinical pathology.

THE CLINICAL AND BIOLOGICAL SIGNIFICANCE OF ESTROGEN RECEPTOR-LOW POSITIVE BREAST CANCER.

A. Green, E. Rakha, N. Mongan, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

NHSBSP type 1 interval cancers: a scientifically valid grouping?

A. Evans, J. Chakrabarti, A. Evans, 2007, Clinical radiology.

The prognostic significance of B lymphocytes in invasive carcinoma of the breast

I. Ellis, A. Green, E. Paish, 2012, Breast Cancer Research and Treatment.

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.

R W Blamey, I. Ellis, R. Blamey, 2006, European journal of cancer.

Reporting needle core biopsies of breast carcinomas

S. Pinder, S. Pinder, I. Ellis, 2003 .

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.

I. Ellis, R. Blamey, C. Elston, 2009, European journal of cancer.

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.

R W Blamey, G. Ball, I. Ellis, 2007, European journal of cancer.

CT staging of loco-regional breast cancer recurrence. A worthwhile practice?

A. Evans, D. Macmillan, J. James, 2009, Clinical radiology.

Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?

E. Rakha, Z. Hodi, Andrew H. S. Lee, 2023, Journal of Clinical Pathology.

Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer

I. Ellis, S. Pinder, R. Rampaul, 2001, Breast Cancer Research.

Brief fixation and hormone receptor expression in breast cancer.

I. Ellis, E. Rakha, Andrew H. S. Lee, 2015, The American journal of surgical pathology.

Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer

G. Ball, I. Ellis, S. Pinder, 2014, Clinical Cancer Research.

National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancer.

I. Ellis, E. Rakha, A. Shaaban, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases.

I. Ellis, E. Rakha, A. Evans, 2008, Breast.

Spindle cell carcinoma of the breast: a case series of a rare histological subtype.

S. Pinder, A. Evans, J. Robertson, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.